DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

company name or ticker

Falling Earnings Estimates Signal Weakness Ahead for Alexion Pharmaceuticals (ALXN)

Wall Street Breakfast: Crude Prices Head To The $30s

Omeros' Reveals Positive Data on OMS721 from Phase II

David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF

Baron Funds Comments on Alexion Pharmaceuticals Inc.

Premarket Biotech Digest: Which Cancer Drug, MannKind's Future, Victoza Trial

This Drugmaker's Incredible Run Looks Far From Done

Alexion Pharmaceuticals has been a biotech investor's dream stock for years and has created a fortune for patient investors. But with a strong product lineup and healthy pipeline, the future looks great, too.

New Strong Sell Stocks for August 18th

The 5 Most Expensive Drugs in the World in 2015

These five drugs will set insurers and patients back anywhere from $375,000 per year to as much as $1.21 million per year.

3 Stocks Dragging The Drugs Industry Downward

See More Articles...